Sampo Oyj will publish its financial results for the first nine months of 2026 on November 4, 2026, at around 8:30 AM. Alongside the report, supplementary presentation materials will be available on their website. An investor conference call will be held the same day at 10:30 AM, featuring key executives including CEO Morten Thorsrud and CFO Lars Kufall Beck. The call will be conducted in English and accessible online, with a recording available afterward. This event provides investors and analysts an opportunity to discuss the company's performance and outlook.
Sampo Oyj's upcoming financial results release is the subject, providing context for readers interested in financials. As of Oct 28, 2026, 64 out of 142 Financials-sector US stocks on Pluang rose while 67 fell. Notable movers include Marsh & McLennan Companies, Inc. at USD 195.09 with a 2.32% increase and a typical hold time of 109 days, and KB Financial Group, Inc. at USD 115.08 with a 2.29% rise and a 34-day hold time.
Alvotech, a global biotech company specializing in biosimilars, will release its financial results for the first nine months of 2026 on November 11 after U.S. market close. A live webcast presentation is scheduled for November 12 at noon, where manag...
Stella-Jones Inc. announced that its CEO Eric Vachon and CFO Silvana Travaglini will participate in the RBC Capital Markets 2026 Global Industrials Conference in New York on November 16, 2026. The company will hold meetings with institutional investo...
Xunce has launched TokenRouters, a platform designed as a one-stop hub for exchanging AI data and specialized tokens to optimize enterprise AI models. The platform addresses the challenge of matching AI resources by integrating datasets, models, appl...
Stella-Jones Inc. announced that its CEO Éric Vachon and CFO Silvana Travaglini will attend the RBC Capital Markets 2026 Global Industrial Products Conference in New York on November 16, 2026. They will meet with institutional investors to discuss th...
Copenhagen Airports has named Sofie Mørck Jarl as its new Chief Financial Officer, effective by March 1, 2027. She previously held senior finance roles at Novo Nordisk and brings experience in strategy, financial leadership, and managing large invest...
